Literature DB >> 29504632

Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology.

Yuh-Chen Kuo1,2, Hann-Chorng Kuo2.   

Abstract

AIMS: To investigate the characteristics of videourodynamic study (VUDS) in females with interstitial cystitis/bladder pain syndrome (IC/BPS) focusing on the etiologies of bladder outlet dysfunction (BOD) and their associations with clinical and urodynamic parameters.
METHODS: IC/BPS females with complete data on symptom assessment, VUDS, the potassium sensitivity test, and cystoscopic hydrodistention were reviewed retrospectively. Diagnoses of bladder dysfunction (hypersensitive bladder, HSB) and BOD including dysfunctional voiding (DV), poor relaxation of the external urethral sphincter (PRES), and bladder neck dysfunction (BND) were made by VUDS. The clinical and urodynamic parameters between patients with normal and abnormal VUDS diagnoses were analyzed.
RESULTS: A total of 348 IC/BPS female patients (mean age 48.8 ± 13.5) were enrolled. HSB was found in 307 (88.2%) patients and BOD in 209 (60.1%). The causes of BOD included DV in 40 (11.5%), PRES in 168 (48.3%), and BND in 1 (0.3%). Patients with DV and BND had higher, and those with PRES had lower detrusor pressures at maximum flow rate (Qmax ) than those with normal tracings. For all BOD patients, univariate logistic regression revealed a significant positive correlation of disease duration and negative correlations of urodynamic volume parameters with BOD in IC/BPS patients. Multivariate logistic regression found a cut-off value of Qmax  ≦ 11 mL/s predicted BOD in IC/BPS with a receiver operating characteristic area of 0.81 (sensitivity = 82.0%, specificity = 68.5%).
CONCLUSIONS: HSB and BOD are common findings on VUDS in IC/BPS females. BOD is associated with duration and hypersensitive bladder. A Qmax  ≦ 11 mL/s predicts BOD in IC/BPS.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  bladder outlet dysfunction; interstitial cystitis; videourodynamic

Mesh:

Year:  2018        PMID: 29504632     DOI: 10.1002/nau.23542

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

Review 1.  Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.

Authors:  Jia-Fong Jhang
Journal:  Toxins (Basel)       Date:  2019-11-04       Impact factor: 4.546

Review 2.  The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.

Authors:  Yao-Lin Kao; Kuan-Hsun Huang; Hann-Chorng Kuo; Yin-Chien Ou
Journal:  Toxins (Basel)       Date:  2019-12-13       Impact factor: 4.546

3.  Diagnostic Value of the Maximum Urethral Closing Pressure in Women With Overactive Bladder Symptoms and Functional Bladder Outlet Obstruction.

Authors:  Su Jin Kim; Hee Jung Choo; Hana Yoon
Journal:  Int Neurourol J       Date:  2022-02-28       Impact factor: 2.835

4.  Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months.

Authors:  Su Jin Kim; Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2022-09-30       Impact factor: 3.038

5.  Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors.

Authors:  Yin-Chien Ou; Kuan-Hsun Huang; Hau-Chern Jan; Hann-Chorng Kuo; Yao-Lin Kao; Kuen-Jer Tsai
Journal:  Toxins (Basel)       Date:  2021-06-02       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.